Table 6.

Proportion of symptomatic TEs according to concomitant medication

	% (n/N)		(95% CI)
Concomitant Medication	Nadroparin	Placebo	Relative risk
Steroids	2.4 (14/586)	4.0 (12/300)	0.60 (0.28-1.28)
G-CSF	0.0 (0/116)	1.7 (1/59)	ND
NSAID	1.2 (1/86)	0.0 (0/49)	ND
Erythropoietin	3.5 (2/57)	3.0 (1/33)	1.16 (0.11-12.29)
Blood and related products	0.0 (0/21)	6.7 (1/15)	ND
Aspirin	5.9 (1/17)	25.0 (2/8)	0.24 (0.02-2.23)

Abbreviation: ND, not determinable; G-CSF, granulocyte colony-stimulating factors; NSAID, nonsteroidal anti-inflammatory drugs